What is the treatment for post-streptococcal glomerulonephritis (PSGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Streptococcal Glomerulonephritis

Treat all patients with penicillin (or erythromycin if penicillin-allergic) regardless of whether active infection is present, combined with supportive management of fluid overload and hypertension using sodium restriction and diuretics. 1, 2

Antibiotic Therapy

Administer antibiotics to all patients even without active infection to reduce streptococcal antigenic load, which is critical for limiting immune complex formation and glomerular inflammation. 1, 2

  • Penicillin is the first-line antibiotic for post-streptococcal glomerulonephritis 1, 2
  • Erythromycin should be used for patients with penicillin allergy 1, 2
  • First-generation cephalosporins (e.g., cephalexin) are appropriate alternatives for non-anaphylactic penicillin allergies or when beta-lactamase producing organisms are suspected 1, 2
  • Third-generation cephalosporins (e.g., ceftriaxone) should be reserved for severe infections or areas with high prevalence of resistant organisms 1, 2
  • During outbreaks, systemic antimicrobials help eliminate nephritogenic strains of Streptococcus pyogenes from the community 1

Supportive Management of Nephritic Syndrome

The cornerstone of treatment is managing the clinical manifestations of acute glomerulonephritis, as the disease is fundamentally self-limiting. 2, 3

Sodium and Fluid Management

  • Restrict dietary sodium to <2.0 g/day to control hypertension and fluid retention 1, 2
  • Monitor fluid status closely, as hypervolemia can lead to congestive heart failure, pulmonary edema, and hypertensive encephalopathy during the acute phase 3

Blood Pressure Control

  • Use diuretics (loop or thiazide) as first-line agents for managing both fluid overload and hypertension 1, 2, 4
  • Target blood pressure <130/80 mmHg (or <125/75 mmHg if proteinuria >1 g/day) 2
  • ACE inhibitors or angiotensin receptor blockers may be effective for hypertension but carry risks of hyperkalemia and temporarily impairing recovery of renal function 4
  • Monitor closely for diuretic-related complications including hyponatremia, hypokalemia, GFR reduction, and volume depletion 1, 2

Additional Supportive Measures

  • Treat metabolic acidosis if serum bicarbonate <22 mmol/L 1, 2
  • Provide dialysis if necessary for severe acute kidney injury with fluid overload unresponsive to diuretics 1
  • Consider treating dyslipidemia in patients with nephrotic syndrome, particularly those with other cardiovascular risk factors 1

Immunosuppressive Therapy

Corticosteroids should be considered ONLY for severe crescentic glomerulonephritis with rapidly progressive renal failure, based on anecdotal evidence with weak quality. 1, 2

  • Do NOT use corticosteroids routinely for typical post-streptococcal glomerulonephritis, as the disease is self-limiting and most patients recover with supportive care alone 1, 2, 5
  • High-dose glucocorticoids and immunosuppressive therapy may be considered for crescentic PSGN, though evidence is limited 1, 2
  • One study showed no advantages of combined immunosuppressants over supportive therapy alone for crescentic disease 5

Monitoring and Follow-Up

The most critical period is the first 7-10 days when hypertension, edema, gross hematuria, and impaired renal function are greatest. 4

  • Assess C3 complement levels at diagnosis and follow serially—C3 should normalize within 8-12 weeks in uncomplicated cases 1, 2
  • If C3 remains low beyond 12 weeks, perform kidney biopsy to exclude complement C3 glomerulonephritis (C3GN) 1, 2
  • Monitor kidney function, blood pressure, proteinuria, and hematuria regularly throughout the disease course 1, 2
  • Kidney biopsy is indicated when diagnosis is uncertain, atypical presentation occurs, or rapidly progressive glomerulonephritis develops 1, 6

Common Pitfalls to Avoid

  • Do not withhold antibiotics even if active infection is no longer present—reducing antigenic load is therapeutic 1, 2
  • Do not use corticosteroids for typical cases—reserve only for severe crescentic disease with rapidly progressive renal failure 1, 2
  • Do not assume chronic kidney disease if proteinuria persists early—most patients make full recovery, though <10% may have persistent microscopic hematuria or proteinuria requiring long-term monitoring 6, 4
  • Be vigilant during the first 7-10 days when complications like hypertensive emergencies and congestive heart failure are most likely 3, 4

References

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Post-Infectious Glomerulonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children.

Medical science monitor : international medical journal of experimental and clinical research, 2010

Research

Acute post-streptococcal glomerulonephritis in children - treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.